FDA Approves New Treatment for Leading Cause of Blindness

Millions of older adults facing wet age-related macular degeneration now have a newly approved treatment option after years of development.

Outlook Therapeutics' Lytenava offers hope to those battling this leading cause of vision loss in seniors.